Member Info for Alwaysone

Price about to move up??

Yes, the ATM - shame short term

This share just refuses to stop rising ....was tipped as the next ARM and can see it now.

Strange heading...another step up tomorrow. Will be 25p by Tuesday.

Closed evens....not too bad today

@Bananaman2. I think the 22p was hindered a little by the markets today to be fair, or we'd be at 20p now. Not too far off and news to follow very soon I'm sure.....will build next week for sure.

aha, the penny really is dropping on the electrolysers. Moving to the 22p as mentioned earlier

Couple of indicators here as well
https://www.asktraders.com/analysis/afc-energy-share-price-falls-even-after-raising-31-6-million/
AFC ENERGY SHARE PRICE FALLS EVEN AFTER RAISING £31.6 MILLION
With the current developments in its business and the global push to move to other energy sources, I feel over the next 12-months we could see AFC Energy move higher.

Yes, spot on there Haggis!!

Should end at 22p today and will break 25p Monday/Tuesday

Only one way for this price now, as the £30M placing is a huge deal and means investors are very confident of AFCs plans.
Plus news on the way very soon to solidfy the raise also. This is probably the best position the company have even been in.
Below 20p will be a distant memory barring the markets bombing!

As I was saying. More to come.

Down due to Nas. ATMs. Boring I know.

Yes, ATMs will ensure a negative close on Nas. Closed tomorrow as you say so can’t see any RNS coming out.

nm

Lost money here a few months ago, seems like a better time to invest after that huge fundraise

ATM

I just can't see it...these comments from the company are doing their best to sound like they should but couldn't say it if any NDAs had been signed

It is also working with a firm called Sciarra Laboratories on a unique technology that sends the drug directly to the lungs using a handheld inhaler or nebuliser.

Tiziana said this new approach, which can be deployed with small molecule drugs such as Gilead Sciences’ (NASDAQ:GILD) Remdesivir, as well as mAbs like Roche Holding’s (SWX:RO) Actemra, has “significant clinical advantages” over the current delivery methods when treating COVID patients

StemPrinter
· Allow Shareholders to benefit from both Tiziana's rapidly developing drug portfolio and the standalone value of StemPrintER as it progresses through its own development milestones and the path to commercialization and allow shareholders to receive the maximum potential value from StemPrintER as a standalone entity.
Notwithstanding that the required approval for the capital reduction will be sought, these considerations remain at an early stage and there can be no guarantee that the demerger will be completed.

he approval of the capital reduction will enable the Board, in due course, to declare distribution in specie of shares in the new StemPrintER entity to existing Tiziana shareholders.

to declare distribution in specie of shares in the new StemPrintER entity to existing Tiziana shareholders.
to declare distribution in specie of shares in the new StemPrintER entity to existing Tiziana shareholders.

That’s a very distorted, optimistic read on the ATM. Making more shares available etc. All the great news and little movement in share price. Spikes sold into. It’s the ATM mainly, 40p placing a bit and the spread imho